AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. (2021)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)01462-8
PubMed Identifier: 34197809
Publication URI: http://europepmc.org/abstract/MED/34197809
Type: Journal Article/Review
Volume: 398
Parent Publication: Lancet (London, England)
Issue: 10296
ISSN: 0140-6736